Glenmark Pharmaceuticals, a research-led integrated global pharmaceutical company, announced that it has received an approval from Drug Controller General of India (DCGI) to conduct clinical trials on Favipiravir Antiviral tablets on COVID-19 patients.

ISO-13485 standard is an international certification that discusses about quality management systems (QMS), which have application in one or more stages of life-cycle of medical devise manufactured by the company.

The market opened in the green on April 30, 2020. The previous trading session witnessed the Sensex going up by 1.89 percent to end at 32,720.16 and the Nifty was up 1.84 percent to close at 9,553.35.

The market opened in the green on April 30, 2020. The previous trading session witnessed the Sensex going up by 1.89 percent to end at 32,720.16 and the Nifty was up 1.84 percent to close at 9,553.35.

The market opened in the green on April 30, 2020. The previous trading session witnessed the Sensex going up by 1.89 percent to end at 32,720.16 and the Nifty was up 1.84 percent to close at 9,553.35.

On the other hand, broader indices have increased by nearly 20 per cent. Even the benchmark indices, Sensex and Nifty gained in the same range.

The market opened in the green on April 30, 2020, overall volumes in futures & options currently stand at 2.28 crore contracts with a turnover of Rs. 11,78,714.39 crore.

EIR comprises of a detailed report from the regulatory investigator based on its visit to the specific facility.

Research and development (R&D) driven integrated pharmaceutical company, Kimia Biosciences Ltd, announced that it has bagged permission for manufacturing and marketing of Azelnidipine API.

If we go by the early indications, the momentum is likely to continue and we may witness a gap-up opening as SGX Nifty is indicating gains of double century at the opening bell. As of now, April month has delivered almost 11 per cent gains and as a result, we can conclude it by saying, ‘All’s well that ends well!